CDC's Grand Rounds Presents “Reducing the Burden of HPV-associated Cancer and Disease through Vaccination in the US.” on Tuesday, February 19, at 1 p.m. (EST).

CDC - Grand Rounds

We are pleased to present the February session of CDC’s Public Health Grand Rounds, “Reducing the Burden of HPV-associated Cancer and Disease through Vaccination in the US.” This session will be available via live webcast from CDC headquarters in Atlanta, Georgia on Tuesday, February19 at 1 p.m. (EST) at http://www.cdc.gov/about/grand-rounds/.

This session of Grand Rounds will explore the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. HPV is the most common sexually transmitted infection in the United States. There are more than 40 HPV types, some of which cause cancers and others which cause genital warts. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease. Currently available HPV vaccines prevent infection from the HPV types that cause about 70% of cervical cancers and the majority of other HPV-attributable cancers. HPV vaccine has been recommended for routine vaccination of 11-12 year-old girls since 2006 and for 11-12 year-old boys since 2011.  

Join us to learn about the HPV vaccination program and how CDC, state and local health departments, and health care providers can work together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.

Tentative future Grand Rounds topics include teen pregnancy, immunization, and hypertension.

Email your questions about this topic before or during the session. Follow us on Twitter #cdcgrandrounds

Presented By:

Mona Saraiya, MD, MPH

CAPT, U.S. Public Health Service

Division of Cancer Prevention and Control

National Center for Chronic Disease Prevention and Health Promotion, CDC

“Public Health Importance of Human Papillomavirus Infection and Disease”

Eileen F. Dunne, MD, MPH

CAPT, U.S. Public Health Service

Epidemiology and Statistics Branch, Division of STD Prevention

National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC

“Overview of HPV Vaccines and Monitoring Vaccine Impact”

Shannon Stokley, MPH

Acting Associate Director of Science, Division of Immunization Services

National Center for Immunization and Respiratory Diseases, CDC

“US HPV Vaccination Program, Progress and Challenges”

Amy Middleman, MD, MSEd, MPH

Associate Professor and Director, Adolescent and Young Adult Immunization 

Texas Children’s Hospital Center for Vaccine Awareness and Research 

“What is Needed to Increase HPV Vaccine Coverage?”

Lauri E. Markowitz, MD

Team Lead, Epidemiology and Statistics Branch, Division of STD Prevention

National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC

“Looking Forward - Global and Domestic HPV Vaccination Programs”

Facilitated By:

Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds 

John Iskander, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds 

Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds 

For non-CDC staff or those outside of the CDC firewall:

A live external webcast will be available. Presentations are archived and posted 48 hours after each session. Due to security measures at CDC’s Roybal campus, non-CDC staff who wish to attend these sessions in person must have prior clearance and a U.S. state-issued photo ID (e.g., driver’s license, U.S. passport).

Names of non-CDC staff (both domestic and international) should be submitted to the Grand Rounds Team. Please note that all information for international visitors must be submitted at least 10 days in advance.

For CDC staff requiring reasonable accommodations:

It is the policy of CDC to provide reasonable accommodations (RA) for qualified individuals with disabilities to ensure their full inclusion in CDC-sponsored training events.  Employees are asked to submit RA requests at least two weeks prior to the training event.  Please e-mail the request to grandrounds@cdc.gov

Grand Rounds is available for Continuing Education.

ALL Continuing Education hours for PHGR are issued online through the CDC/ATSDR Training and Continuing Education Online system. If you have questions, e-mail or call Learner Support at 1-800-418-7246 (1-800-41TRAIN).

Those who attend PHGR either in person, Envision, IPTV, or “web on demand” and who wish to receive Continuing Education must complete the online seminar evaluation. Thirty days from the initial seminar the course number will change to WD1640 and will be available for continuing education until January 21, 2014. The course code for PHGR is PHGR10.

Target Audience: Physicians, nurses, epidemiologists, pharmacists, veterinarians, certified health education specialists, laboratorians, others

Objectives: 

1. List key measures of burden of disease involving morbidity, mortality, and/or cost.
2. Describe evidence-based preventive interventions and the status of their implementations.
3. Identify one key prevention science research gap.
4. Name one key indicator by which progress and meeting prevention goals is measured.

CE certificates can be printed from your computer immediately upon completion of your online evaluation. A cumulative transcript of all CDC/ATSDR CE’s obtained through the TCE Online System will be maintained for each user. We hope that this will assist CDC staff and other public health professionals to fulfill the requirements for their professional licenses and certificates.

Learn more about continuing education on the Grand Rounds website.